Alessandro Magini Selected Research

Infections

1/2012

Roles of the amino terminal region and repeat region of the Plasmodium berghei circumsporozoite protein in parasite infectivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Magini Research Topics

Disease

6	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2019 - 01/2011
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2010
2	Neuroblastoma 03/2019 - 05/2016
2	Tuberous Sclerosis (Bourneville's Disease) 05/2018 - 01/2017
2	Neoplasms (Cancer) 05/2018 - 03/2013
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2017 - 08/2014
2	Sandhoff Disease (Sandhoff's Disease) 08/2014 - 02/2010
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Central Nervous System Cavernous Hemangioma 01/2019
1	Carcinogenesis 05/2018
1	Neurologic Manifestations (Neurological Manifestations) 05/2018
1	Astrocytoma (Pilocytic Astrocytoma) 01/2017
1	Glycogen Storage Disease Type II (Pompe's Disease) 04/2015
1	Clinical Deterioration 04/2015
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 04/2015
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 08/2014
1	Sphingolipidoses (Sphingolipidosis) 08/2014
1	Prostatic Neoplasms (Prostate Cancer) 06/2014
1	Starvation 04/2013
1	Infections 01/2012
1	Malaria 01/2012

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2010
3	TOR Serine-Threonine KinasesIBA 01/2019 - 05/2016
3	Hexosaminidases (Hexosaminidase)IBA 01/2015 - 06/2014
2	Glycoside Hydrolases (Endoglycosidases)IBA 03/2019 - 01/2015
2	LipidsIBA 03/2019 - 01/2015
2	Sirolimus (Rapamycin)FDA Link 01/2019 - 05/2016
2	MTOR InhibitorsIBA 01/2019 - 05/2016
2	trans-sodium crocetinate (crocetin)IBA 05/2018 - 01/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 05/2018 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 03/2013
1	GlycosphingolipidsIBA 03/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	Everolimus FDA Link 01/2019
1	Biological ProductsIBA 05/2016
1	EnzymesIBA 04/2015
1	poly(lactide) (polylactic acid)IBA 04/2015
1	GlycogenIBA 04/2015
1	alpha-Glucosidases (Acid Maltase)IBA 04/2015
1	AcidsIBA 04/2015
1	GalactosidasesIBA 01/2015
1	GangliosidesIBA 01/2015
1	Pyrimethamine (Daraprim)FDA Link 08/2014
1	G(M2) Ganglioside (Ganglioside GM2)IBA 08/2014
1	SphingolipidsIBA 08/2014
1	IsoenzymesIBA 06/2014
1	Messenger RNA (mRNA)IBA 06/2014
1	Hexosaminidase A (Hex A)IBA 06/2014
1	Transfer RNA (tRNA)IBA 04/2013
1	Amino Acids FDA Link 04/2013
1	beta-N-AcetylhexosaminidasesIBA 02/2010

Therapy/Procedure

2	Therapeutics 01/2019 - 08/2014